NEKTAR THERAPEUTICS (NKTR) Operating margin 2016–2025
NEKTAR THERAPEUTICS (NKTR) operating margin by fiscal year — reported operating income divided by reported revenue.
-253.7%FY2025 · since FY2016: -68.2% → -253.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -253.7% | -146.8 pp |
| FY2024 | -106.9% | +185.7 pp |
| FY2023 | -292.6% | +116.0 pp |
| FY2022 | -408.6% | +29.1 pp |
| FY2021 | -437.8% | -159.8 pp |
| FY2020 | -278.0% | +105.9 pp |
| FY2019 | -383.9% | -441.6 pp |
| FY2018 | 57.6% | +77.0 pp |
| FY2017 | -19.4% | +48.8 pp |
| FY2016 | -68.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice